ERGO Stock - Entia Biosciences, Inc.
Unlock GoAI Insights for ERGO
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|
| Revenue | $265,466 | $346,910 | $656,342 | $314,746 | $369,273 |
| Gross Profit | $173,967 | $215,903 | $410,871 | $183,623 | $261,808 |
| Gross Margin | 65.5% | 62.2% | 62.6% | 58.3% | 70.9% |
| Operating Income | $-1,167,379 | $-1,915,956 | $-1,770,934 | $-2,681,566 | $-1,080,684 |
| Net Income | $-1,472,664 | $-2,409,334 | $-2,636,300 | $-3,249,516 | $-1,527,077 |
| Net Margin | -554.7% | -694.5% | -401.7% | -1032.4% | -413.5% |
| EPS | $-0.05 | $-0.10 | $-0.28 | $-0.43 | $-0.21 |
Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products in the United States. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical foods, nutraceuticals, cosmetics, and other products. The company's portfolio of formulations include ErgoD2, a pharmaceutical grade organic compound from whole food that contains the micro-nutrients; L-Ergothioneine, a naturally occurring amino acid and master antioxidant; and vitamin D, an antioxidant. In addition, it is also developing products for the chronic kidney disease and other diseases, as well as providing cosmeceuticals and other beauty products under the GROH brand name. Entia Biosciences, Inc. offers its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was founded in 2007 and is headquartered in Sherwood, Oregon.
Visit WebsiteEarnings History & Surprises
ERGOEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2016 | Dec 31, 2016 | — | $-0.02 | — | — |
Q4 2016 | Nov 14, 2016 | — | $-0.01 | — | — |
Q3 2016 | Sep 29, 2016 | — | $-0.01 | — | — |
Q1 2016 | Mar 31, 2016 | — | $-0.01 | — | — |
Q4 2015 | Dec 31, 2015 | — | $-0.01 | — | — |
Q3 2015 | Sep 30, 2015 | — | $-0.01 | — | — |
Q2 2015 | Jun 30, 2015 | — | $-0.05 | — | — |
Q1 2015 | Mar 31, 2015 | — | $-0.05 | — | — |
Q4 2014 | Dec 31, 2014 | — | $-0.06 | — | — |
Q3 2014 | Sep 30, 2014 | — | $-0.06 | — | — |
Q2 2014 | Jun 30, 2014 | — | $-0.06 | — | — |
Q1 2014 | Mar 31, 2014 | — | $-0.06 | — | — |
Q4 2013 | Dec 31, 2013 | — | $-0.14 | — | — |
Q3 2013 | Sep 30, 2013 | — | $-0.07 | — | — |
Q2 2013 | Jun 30, 2013 | — | $-0.14 | — | — |
Q1 2013 | Mar 31, 2013 | — | $-0.06 | — | — |
Q4 2012 | Dec 31, 2012 | — | $-0.04 | — | — |
Q3 2012 | Sep 30, 2012 | — | $-0.04 | — | — |
Q2 2012 | Jun 30, 2012 | — | $-0.05 | — | — |
Q1 2012 | Mar 31, 2012 | — | $-0.04 | — | — |
Latest News
Frequently Asked Questions about ERGO
What is ERGO's current stock price?
What is the analyst price target for ERGO?
What sector is Entia Biosciences, Inc. in?
What is ERGO's market cap?
Does ERGO pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to ERGO for comparison